121 related articles for article (PubMed ID: 33021299)
1. Cytotoxic (
Wise DE; Gamble AJ; Arkawazi SW; Walton PH; Galan MC; O'Hagan MP; Hogg KG; Marrison JL; O'Toole PJ; Sparkes HA; Lynam JM; Pringle PG
Dalton Trans; 2020 Nov; 49(43):15219-15230. PubMed ID: 33021299
[TBL] [Abstract][Full Text] [Related]
2. Ruthenium(II) Diphosphine Complexes with Mercapto Ligands That Inhibit Topoisomerase IB and Suppress Tumor Growth In Vivo.
da Silva MM; Ribeiro GH; de Camargo MS; Ferreira AG; Ribeiro L; Barbosa MIF; Deflon VM; Castelli S; Desideri A; Corrêa RS; Ribeiro AB; Nicolella HD; Ozelin SD; Tavares DC; Batista AA
Inorg Chem; 2021 Sep; 60(18):14174-14189. PubMed ID: 34477373
[TBL] [Abstract][Full Text] [Related]
3. cis-1,3,5-Triaminocyclohexane as a facially capping ligand for ruthenium(II).
Gamble AJ; Lynam JM; Thatcher RJ; Walton PH; Whitwood AC
Inorg Chem; 2013 Apr; 52(8):4517-27. PubMed ID: 23517123
[TBL] [Abstract][Full Text] [Related]
4. Lapachol in the Design of a New Ruthenium(II)-Diphosphine Complex as a Promising Anticancer Metallodrug.
Oliveira KM; Honorato J; Demidoff FC; Schultz MS; Netto CD; Cominetti MR; Correa RS; Batista AA
J Inorg Biochem; 2021 Jan; 214():111289. PubMed ID: 33137682
[TBL] [Abstract][Full Text] [Related]
5. Half-Sandwich Ru(
Lenis-Rojas OA; Robalo MP; Tomaz AI; Fernandes AR; Roma-Rodrigues C; Teixeira RG; Marques F; Folgueira M; Yáñez J; Gonzalez AA; Salamini-Montemurri M; Pech-Puch D; Vázquez-García D; Torres ML; Fernández A; Fernández JJ
Inorg Chem; 2021 Mar; 60(5):2914-2930. PubMed ID: 33570919
[TBL] [Abstract][Full Text] [Related]
6. DNA binding properties, histidine interaction and cytotoxicity studies of water soluble ruthenium(ii) terpyridine complexes.
Lazić D; Arsenijević A; Puchta R; Bugarčić ŽD; Rilak A
Dalton Trans; 2016 Mar; 45(11):4633-46. PubMed ID: 26855406
[TBL] [Abstract][Full Text] [Related]
7. Reversible pH-Responsive Behavior of Ruthenium(II) Arene Complexes with Tethered Carboxylate.
Martínez-Peña F; Infante-Tadeo S; Habtemariam A; Pizarro AM
Inorg Chem; 2018 May; 57(9):5657-5668. PubMed ID: 29688005
[TBL] [Abstract][Full Text] [Related]
8. Similarities and differences in d
Gilewska A; Barszcz B; Masternak J; Kazimierczuk K; Sitkowski J; Wietrzyk J; Turlej E
J Biol Inorg Chem; 2019 Jun; 24(4):591-606. PubMed ID: 31115765
[TBL] [Abstract][Full Text] [Related]
9. New ruthenium(II) coordination compounds possessing bidentate aminomethylphosphane ligands: synthesis, characterization and preliminary biological study in vitro.
Płotek M; Starosta R; Komarnicka UK; Skórska-Stania A; Jeżowska-Bojczuk M; Stochel G; Kyzioł A
Dalton Trans; 2015 Aug; 44(31):13969-78. PubMed ID: 26155929
[TBL] [Abstract][Full Text] [Related]
10. Metal complexes as DNA intercalators.
Liu HK; Sadler PJ
Acc Chem Res; 2011 May; 44(5):349-59. PubMed ID: 21446672
[TBL] [Abstract][Full Text] [Related]
11. Comparative solution equilibrium and structural studies of half-sandwich ruthenium(II)(η
Poljarević JM; Tamás Gál G; May NV; Spengler G; Dömötör O; Savić AR; Grgurić-Šipka S; Enyedy ÉA
J Inorg Biochem; 2018 Apr; 181():74-85. PubMed ID: 29407910
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic Ruthenium(II) Complexes Containing a Dangling Pyridine: Selectivity for Diseased Cells Mediated by pH-Dependent DNA Binding.
Sangeetha S; Murali M
Inorg Chem; 2022 Feb; 61(6):2864-2882. PubMed ID: 35099196
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor activity and mechanism of apoptosis of A549 induced by ruthenium complex.
Sun D; Mou Z; Li N; Zhang W; Wang Y; Yang E; Wang W
J Biol Inorg Chem; 2016 Dec; 21(8):945-956. PubMed ID: 27620172
[TBL] [Abstract][Full Text] [Related]
14. On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7).
Leite CM; de Araujo-Neto JH; Corrêa RS; Colina-Vegas L; Martínez-Otero D; Martins PR; Silva CG; Batista AA
Anticancer Agents Med Chem; 2021; 21(9):1172-1182. PubMed ID: 32838726
[TBL] [Abstract][Full Text] [Related]
15. Half sandwich Ru(ii)-acylthiourea complexes: DNA/HSA-binding, anti-migration and cell death in a human breast tumor cell line.
Colina-Vegas L; Luna-Dulcey L; Plutín AM; Castellano EE; Cominetti MR; Batista AA
Dalton Trans; 2017 Oct; 46(38):12865-12875. PubMed ID: 28920989
[TBL] [Abstract][Full Text] [Related]
16. Heteropentanuclear Oxalato-Bridged nd-4f (n=4, 5) Metal Complexes with NO Ligand: Synthesis, Crystal Structures, Aqueous Stability and Antiproliferative Activity.
Kuhn PS; Cremer L; Gavriluta A; Jovanović KK; Filipović L; Hummer AA; Büchel GE; Dojčinović BP; Meier SM; Rompel A; Radulović S; Tommasino JB; Luneau D; Arion VB
Chemistry; 2015 Sep; 21(39):13703-13. PubMed ID: 26260662
[TBL] [Abstract][Full Text] [Related]
17. Systematic evaluation of the antitumor activity of three ruthenium polypyridyl complexes.
Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
J Inorg Biochem; 2021 Dec; 225():111616. PubMed ID: 34555601
[TBL] [Abstract][Full Text] [Related]
18. Ru(II)/clotrimazole/diphenylphosphine/bipyridine complexes: Interaction with DNA, BSA and biological potential against tumor cell lines and Mycobacterium tuberculosis.
Colina-Vegas L; Dutra JL; Villarreal W; de A Neto JH; Cominetti MR; Pavan F; Navarro M; Batista AA
J Inorg Biochem; 2016 Sep; 162():135-145. PubMed ID: 27383651
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic Ruthenium(II) Complexes of Pyrazolylbenzimidazole Ligands That Inhibit VEGFR2 Phosphorylation.
Chakraborty A; Roy S; Chakraborty MP; Roy SS; Purkait K; Koley TS; Das R; Acharya M; Mukherjee A
Inorg Chem; 2021 Dec; 60(23):18379-18394. PubMed ID: 34780170
[TBL] [Abstract][Full Text] [Related]
20. Ru(II)/diclofenac-based complexes: DNA, BSA interaction and their anticancer evaluation against lung and breast tumor cells.
Oliveira KM; Honorato J; Gonçalves GR; Cominetti MR; Batista AA; Correa RS
Dalton Trans; 2020 Sep; 49(36):12643-12652. PubMed ID: 32870224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
